Preston Klassen

Insider Reports History

Entity
Individual
Location
3344 N. Torrey Pines Court, Suite 200, La Jolla, California
Signature
Christopher Aker, Attorney in Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Preston Klassen:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Metacrine, Inc. Director Common Stock 1.38M $651K $0.47 Mar 23, 2023 Direct
Regulus Therapeutics Inc. President & Head of R & D, Director Stock Option (Right to Buy) 528K May 20, 2024 Direct
Metacrine, Inc. Director Stock Option (right to buy) 0 Mar 23, 2023 Direct

Insider Reports Filed by Preston Klassen

Symbol Company Period Transactions Value $ Form Type Date Filed Role
RGLS Regulus Therapeutics Inc. May 20, 2024 1 $0 4 May 21, 2024 President & Head of R & D, Director
RGLS Regulus Therapeutics Inc. Jan 12, 2024 1 $0 4 Jan 17, 2024 President & Head of R & D, Director
RGLS Regulus Therapeutics Inc. Aug 10, 2023 1 $0 4 Aug 14, 2023 President & Head of R & D, Director
RGLS Regulus Therapeutics Inc. Jun 12, 2023 1 $0 4 Jun 12, 2023 President & Head of R & D
RGLS Regulus Therapeutics Inc. Jun 12, 2023 0 $0 3 Jun 12, 2023 President & Head of R & D
MTCR Metacrine, Inc. Mar 23, 2023 2 -$396K 4 Mar 24, 2023 Director
ZURA Zura Bio Ltd Mar 20, 2023 0 $0 3 Mar 21, 2023 President and COO
MTCR Metacrine, Inc. Jan 26, 2023 1 -$157K 4 Jan 27, 2023 President & CEO, Director
MTCR Metacrine, Inc. Apr 19, 2022 2 -$22.5K 4 Apr 20, 2022 President & CEO, Director
MTCR Metacrine, Inc. Apr 14, 2022 1 $0 4 Apr 18, 2022 President & CEO, Director
MTCR Metacrine, Inc. Feb 27, 2022 2 $0 4 Mar 1, 2022 President & CEO, Director
MTCR Metacrine, Inc. May 20, 2021 1 $74.7K 4 May 20, 2021 President & CEO, Director